Abstract
Clarithromycin-based regimens are commonly used as a first-line therapy for Helicobacter pylori-positive patients; however, resistance to clarithromycin has led to treatment failures. The aim of this study was to evaluate the feasibility of using stool samples to detect the presence of H. pylori DNA while concurrently detecting mutations associated with resistance to clarithromycin. For this purpose, total DNA was extracted from 294 raw stool specimens from H. pylori-positive and -negative patients. TaqMan real-time PCR amplification was used to detect the presence of H. pylori as well as to predict the phenotype of the organism and the related outcome for patients treated with clarithromycin. Clarithromycin resistance was determined upon analysis of the PCR result. Patients were also tested by a urea breath test and were subjected to esophagogastroduodenoscopy, followed by histology, culture, and a rapid urease test, in order to obtain a consensus patient infection status. Of 294 total stool samples, 227 were deemed true positive. The sensitivity of H. pylori detection by PCR was 93.8%. Of 213 true-positive samples that were sequenced, 36.2% showed point mutations associated with clarithromycin resistance (A2142C, A2142G, A214...Continue Reading
References
Aug 15, 1996·FEMS Microbiology Letters·Y J Debets-OssenkoppC M Vandenbroucke-Grauls
Feb 1, 1996·Antimicrobial Agents and Chemotherapy·J VersalovicM F Go
Jul 16, 1999·Lancet·D VairaG N Tytgat
Mar 14, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·D VairaM Miglioli
Feb 21, 2007·Helicobacter·Josette RaymondNicolas Kalach
Jan 4, 2008·Journal of Gastroenterology and Hepatology·Shaohua ChenChaohui Yu
Dec 17, 2009·The Journal of Antimicrobial Chemotherapy·Vincenzo De FrancescoDino Vaira
Jan 19, 2010·Internal and Emergency Medicine·Dino VairaJohn Holton
Apr 30, 2010·The New England Journal of Medicine·Kenneth E L McColl
Dec 30, 2010·Antimicrobial Agents and Chemotherapy·Jyh-Ming LiouJaw-Town Lin
Aug 9, 2013·BMJ : British Medical Journal·Luigi GattaCarmelo Scarpignato
Sep 1, 2015·Gastroenterology Clinics of North America·Francis MégraudPhilippe Lehours
Sep 4, 2015·Molecular and Cellular Probes·Yan Chun ZhuKimberlee A Musser
Dec 24, 2015·Alimentary Pharmacology & Therapeutics·I ThungM A Valasek
Apr 23, 2016·Gastroenterology·Carlo A FalloneJohn K Marshall
Nov 2, 2016·Gut·P MalfertheinerUNKNOWN European Helicobacter and Microbiota Study Group and Consensus panel
Nov 30, 2016·World Journal of Gastroenterology : WJG·Denise E BrennanDeirdre McNamara
Jan 11, 2017·The American Journal of Gastroenterology·William D CheySteven F Moss
Citations
Sep 12, 2018·Helicobacter·Sabine SkrebinskaEmilie Bessède
Nov 30, 2018·Current Opinion in Gastroenterology·Sinéad M SmithDeirdre McNamara
Dec 21, 2018·Journal of Clinical Microbiology·Toshihiko KakiuchiMuneo Matsuo
Apr 17, 2019·Helicobacter·Mireia BaylinaIgnasi Puig
Jan 31, 2020·Journal of Clinical Microbiology·Maxime PichonChristophe Burucoa
Jun 28, 2018·F1000Research·Shamshul Ansari, Yoshio Yamaoka
Jul 25, 2018·World Journal of Gastroenterology : WJG·Andrea IannoneEnzo Ierardi
Dec 17, 2019·PloS One·Natalie Clines, Erin Beckman
May 26, 2020·BMC Microbiology·Martina LeonardiElena Pomari
Sep 19, 2019·World Journal of Gastroenterology : WJG·Daniel PohlKaroline Wagner
Aug 25, 2020·Current Treatment Options in Gastroenterology·Nasir Saleem, Colin W Howden
Nov 25, 2020·BMC Gastroenterology·Toshihiko KakiuchiMuneaki Matsuo
Feb 5, 2021·Journal of Clinical Microbiology·Rebecca Marrero RolonRobin Patel
Jun 3, 2021·Journal of Clinical Medicine·Maria Pina Dore, Giovanni Mario Pes
Jun 12, 2021·Journal of Gastroenterology and Hepatology·Rachel Gingold-BelferDoron Boltin
Aug 16, 2021·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Enming QiuShuai Han
Aug 28, 2021·Diagnostics·Hang Yang, Bing Hu